Clinical Trials Directory

Trials / Withdrawn

WithdrawnNCT04353947

Induction and Recognition of Emotions

Induction and Recognition of Emotions in Healthy Older Adults, Alzheimer's Disease and Parkinson's Disease

Status
Withdrawn
Phase
Study type
Observational
Enrollment
0 (actual)
Sponsor
University of Valencia · Academic / Other
Sex
All
Age
65 Years – 99 Years
Healthy volunteers
Accepted

Summary

This study evaluates the differences in cognitive function between healthy older adults, older adults with mild Alzheimer's type dementia and older adults with Parkinson's disease and if there are differences in valence assessment and activation that produce them a mood induction task. Subjects are assessed using neuropsychological tests and then a mood induction task based on movie clips is applied.

Detailed description

Different neuropsychological tests will be used to assess the differences in cognitive function in the different groups, whose scores are expected to be lower in the group of older adults with Alzheimer's disease (AD) and older adults with Parkinson's disease (PD). After studying the cognitive function in the different groups, we proceed to check through a task based on movie clips if there are also differences in the valence assessment (liking/disliking depending on the emotion induced by scenes from different films) and activation (excitement caused by each one of the movie scenes), hoping to find differences for the negative emotions taking into account the cognitive difficulties that both (the EA group and the EP group) may have for processing this type of cognitively more demanding information; instead, it is possible that the positivity effect continues to affect these patients so that for positive emotions there are no differences between the different groups.

Conditions

Interventions

TypeNameDescription
DIAGNOSTIC_TESTMini Cognitive Examination (MCE)This test provides information on temporal and spatial orientation, fixation, concentration and calculation, memory and language and construction.
DIAGNOSTIC_TESTBeck Depression Inventory-II (BDI-II)This test evaluates the absence or presence of depressive symptoms.
DIAGNOSTIC_TESTGlobal Deterioration Scale (GDS)This scale measures the level of deterioration of the subject.
DIAGNOSTIC_TESTMemory alteration test (M@T)In this test different memory subtypes are evaluated.
DIAGNOSTIC_TESTSpanish-Complutense Verbal Learning Test (TAVEC)This test is used to assess immediate memory, deferred memory and learning ability.
DIAGNOSTIC_TESTBarcelona test (BT)This test evaluates categorical evocation and verbal fluency. The categorical recall subtest consists of recalling the maximum number of words linked to a specific category "animals" in 1 minute. In the case of verbal fluency, the subject is asked to evoke the maximum number of words that begin with the letter "p" in 3 minutes.
DIAGNOSTIC_TESTRey-Osterrieth Complex Figure Test (ROCFT)In this test, the person must carefully copy a complex geometric drawing, which must be memorized later. The first part evaluates multiple cognitive processes such as planning, motor skills, working memory, and visual-constructive and spatial skills. In the second part, memory is evaluated.
DIAGNOSTIC_TESTFrontal assessment battery (FAB)This test is a composite tool for assessing executive functions related to the frontal lobe.
DIAGNOSTIC_TESTPositive and Negative Affect Scale (PANAS)It is a self-report questionnaire made up of 20 items (10 of positive affect and another 10 of negative affect) that the subject must answer, obtaining in this way a score in positive affectivity (AP subscale) and another in negative affectivity (AN subscale).
DIAGNOSTIC_TESTAuto-Assessment Manikins (SAM)It is a self-report questionnaire that assesses the emotional response of the subject, in this case, through a mood induction task that plays different films scenes.

Timeline

Start date
2020-03-02
Primary completion
2020-10-30
Completion
2020-11-30
First posted
2020-04-21
Last updated
2021-05-06

Locations

1 site across 1 country: Spain

Source: ClinicalTrials.gov record NCT04353947. Inclusion in this directory is not an endorsement.